Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.49722 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.49626 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.49369 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.47217 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.47854 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.52509 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.49343 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.47954 | 71 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.48049 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.48703 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.47987 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.41878 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.49433 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.48578 | 71 |